Geographically, North America dominated the biopsy needles market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for biopsy needles market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.
This report identifies the biopsy needles market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the biopsy needles market.
This report segments the biopsy needles market on the basis of needle type, cancer type and regional market as follows:
- Biopsy needles market research report is classified on the basis of needle type. Some of the major needle types covered in this report are as follows: Disposable Needle and Non Disposable Needle
- Biopsy needles market research report is classified on the basis of cancer type. Some of the major cancer type covered in this report are as follows: Bone Marrow Cancer, Breast Cancer, Lung Cancer, Liver Cancer, Prostate Cancer and Others
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the biopsy needles market. Some of the major companies’ profiles in detail are as follows:
- Medax Medical Devices
- Creganna Medica
- Angiotech
- Argon Medical devices
- Cardinal Health, Inc.